(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 13.05% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.58%.
Iradimed's revenue in 2024 is $65,562,296.On average, 1 Wall Street analysts forecast IRMD's revenue for 2024 to be $938,567,403, with the lowest IRMD revenue forecast at $938,567,403, and the highest IRMD revenue forecast at $938,567,403.
In 2025, IRMD is forecast to generate $1,001,754,820 in revenue, with the lowest revenue forecast at $1,001,754,820 and the highest revenue forecast at $1,001,754,820.